Literature DB >> 19828632

The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum.

Arron Hearn1, Ian A York, Kenneth L Rock.   

Abstract

Aminopeptidases in the endoplasmic reticulum (ER) can cleave antigenic peptides and in so doing either create or destroy MHC class I-presented epitopes. However, the specificity of this trimming process overall and of the major ER aminopeptidase ERAP1 in particular is not well understood. This issue is important because peptide trimming influences the magnitude and specificity of CD8 T cell responses. By systematically varying the N-terminal flanking sequences of peptides in a cell-free biochemical system and in intact cells, we elucidated the specificity of ERAP1 and of ER trimming overall. ERAP1 can cleave after many amino acids on the N terminus of epitope precursors but does so at markedly different rates. The specificity seen with purified ERAP1 is similar to that observed for trimming and presentation of epitopes in the ER of intact cells. We define N-terminal sequences that are favorable or unfavorable for Ag presentation in ways that are independent from the epitopes core sequence. When databases of known presented peptides were analyzed, the residues that were preferred for the trimming of model peptide precursors were found to be overrepresented in N-terminal flanking sequences of epitopes generally. These data define key determinants in the specificity of Ag processing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828632      PMCID: PMC2855122          DOI: 10.4049/jimmunol.0803663

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  The murine cytomegalovirus pp89 immunodominant H-2Ld epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide.

Authors:  C Knuehl; P Spee; T Ruppert; U Kuckelkorn; P Henklein; J Neefjes; P M Kloetzel
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

2.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 3.  Protein degradation and the generation of MHC class I-presented peptides.

Authors:  Kenneth L Rock; Ian A York; Tomo Saric; Alfred L Goldberg
Journal:  Adv Immunol       Date:  2002       Impact factor: 3.543

4.  Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.

Authors:  Eric Reits; Alexander Griekspoor; Joost Neijssen; Tom Groothuis; Kees Jalink; Peter van Veelen; Hans Janssen; Jero Calafat; Jan Wouter Drijfhout; Jacques Neefjes
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

5.  ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum.

Authors:  Thomas Serwold; Federico Gonzalez; Jennifer Kim; Richard Jacob; Nilabh Shastri
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

Review 6.  The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides.

Authors:  Alfred L Goldberg; Paolo Cascio; Tomo Saric; Kenneth L Rock
Journal:  Mol Immunol       Date:  2002-10       Impact factor: 4.407

7.  The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues.

Authors:  Ian A York; Shih-Chung Chang; Tomo Saric; Jennifer A Keys; Janice M Favreau; Alfred L Goldberg; Kenneth L Rock
Journal:  Nat Immunol       Date:  2002-11-18       Impact factor: 25.606

8.  An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides.

Authors:  Tomo Saric; Shih-Chung Chang; Akira Hattori; Ian A York; Shirley Markant; Kenneth L Rock; Masafumi Tsujimoto; Alfred L Goldberg
Journal:  Nat Immunol       Date:  2002-11-18       Impact factor: 25.606

9.  Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase.

Authors:  J Beninga; K L Rock; A L Goldberg
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

10.  Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells.

Authors:  G Lauvau; K Kakimi; G Niedermann; M Ostankovitch; P Yotnda; H Firat; F V Chisari; P M van Endert
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  55 in total

1.  Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens.

Authors:  Sergey S Seregin; David P W Rastall; Irini Evnouchidou; Charles F Aylsworth; Dionisia Quiroga; Ram P Kamal; Sarah Godbehere-Roosa; Christopher F Blum; Ian A York; Efstratios Stratikos; Andrea Amalfitano
Journal:  Autoimmunity       Date:  2013-09-13       Impact factor: 2.815

2.  Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).

Authors:  Despoina Koumantou; Eilon Barnea; Adrian Martin-Esteban; Zachary Maben; Athanasios Papakyriakou; Anastasia Mpakali; Paraskevi Kokkala; Harris Pratsinis; Dimitris Georgiadis; Lawrence J Stern; Arie Admon; Efstratios Stratikos
Journal:  Cancer Immunol Immunother       Date:  2019-06-20       Impact factor: 6.968

3.  Characterizing the specificity and cooperation of aminopeptidases in the cytosol and endoplasmic reticulum during MHC class I antigen presentation.

Authors:  Arron Hearn; Ian A York; Courtney Bishop; Kenneth L Rock
Journal:  J Immunol       Date:  2010-03-29       Impact factor: 5.422

4.  Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.

Authors:  Pablo Guasp; Elena Lorente; Adrian Martín-Esteban; Eilon Barnea; Paolo Romania; Doriana Fruci; JonasJ W Kuiper; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2019-05-15       Impact factor: 5.911

5.  The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.

Authors:  Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Nimman Satumtira; Martha L Dorris; Mylinh T Nguyen; Robert E Hammer; Tri M Tran; Robert A Colbert; Joel D Taurog; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2017-02-10       Impact factor: 5.911

6.  The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.

Authors:  Pablo Guasp; Eilon Barnea; M Francisca González-Escribano; Anaïs Jiménez-Reinoso; José R Regueiro; Arie Admon; José A López de Castro
Journal:  J Biol Chem       Date:  2017-04-26       Impact factor: 5.157

7.  Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1.

Authors:  Dimitra Georgiadou; Arron Hearn; Irini Evnouchidou; Angeliki Chroni; Leondios Leondiadis; Ian A York; Kenneth L Rock; Efstratios Stratikos
Journal:  J Immunol       Date:  2010-06-30       Impact factor: 5.422

8.  Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD).

Authors:  Geert P M Mommen; Christian K Frese; Hugo D Meiring; Jacqueline van Gaans-van den Brink; Ad P J M de Jong; Cécile A C M van Els; Albert J R Heck
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

9.  Substantial Influence of ERAP2 on the HLA-B*40:02 Peptidome: Implications for HLA-B*27-Negative Ankylosing Spondylitis.

Authors:  Elena Lorente; Jennifer Redondo-Antón; Adrian Martín-Esteban; Pablo Guasp; Eilon Barnea; Pilar Lauzurica; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2019-09-17       Impact factor: 5.911

Review 10.  The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.

Authors:  C Vitulano; V Tedeschi; F Paladini; R Sorrentino; M T Fiorillo
Journal:  Clin Exp Immunol       Date:  2017-08-30       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.